Industry
From U.S. (Toll Free) : +16467917070    |   UK : +442030260021     |    sales@businessmarketinsights.com

Middle East and Africa Pain Management Devices Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Product Type (Neuromodulation Devices, Ablation Devices, Analgesic Infusion Pumps); Application (Neuropathic Pain, Cancer Pain, Facial Pain and Migraine, Musculoskeletal Pain, Others), Country

Report Code :  TIPRE00016231
No. of Pages :  90
Published Month :  Nov 2020
Category :  Life Sciences
$299 per month

Best Plan
  • All Reports in One Industry
  • All Reports Read Access
  • Subscription Duration : 12 Months
  • Monthly New Reports Added
  • $1200 Yearly Saving

Market Introduction

Pain management is a part of medical discipline, which eases the suffering of the patients having chronic pain. It is different than acute pain as acute pain has a sudden onset of action, whereas chronic pain persists for a longer duration, which leads to the need for its management. Pain management devices are medical devices that are used in the management of different types of pain, such as cancer pain, nociceptive pain, neuropathic pain, musculoskeletal pain, and others. Spinal cord stimulators, analgesic infusion pumps, transcutaneous electrical nerve stimulation devices, and ablation devices are various types of pain management devices available in the market.

Market Overview and Dynamics

The Middle East & Africa (MEA) pain management devices market is expected to reach US$  235.72 million by 2027 from US$  140.15 million in 2019. The market is expected  to grow with a CAGR of 6.8% from 2020 to 2027. Factors driving the market growth include growing Incidences of chronic pain and market player initiatives. Whereas, the market is likely to have negative impact due to the high cost of pain management devices, such as its nearly impossible for the middle class to effort pain management devices.

Key Market Segments

In terms of Product, the neuromodulation devices held the larger share of the pain management devices market in 2019 and is anticipated to register the highest CAGR in the market during the forecast period. In terms of the application , the neuropathic pain segment held the larger share of the market in 2019. Moreover, musculoskeletal pain segment is anticipated to register the highest CAGR in the market during the forecast period.

Major Sources and Companies Listed

Some of the major primary and secondary sources for pain management devices Market included in the report are, World Health Organization, National, and National Center for Biotechnology Information

Reasons to buy the report

  • To understand the Middle East & Africa (MEA) pain management devices market landscape and identify market segments that are most likely to guarantee a strong return
  • Stay ahead of the race by comprehending the ever-changing competitive landscape for Middle East & Africa (MEA) pain management devices market
  • Efficiently plan M&A and partnership deals in Middle East & Africa (MEA) Pain Management Devices market by identifying market segments with the most promising probable sales
  • Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segments of Middle East & Africa (MEA) pain management devices market.
  • Obtain market revenue forecast for market by various segments from 2019 to 2027 in North America

 

Pain Management Devices Market –

By Type

  • Neuromodulation Devices
    • Transcutaneous Electrical Nerve Stimulation (TENS) Devices
    • Spinal Cord Stimulation (SCS) Devices
  • Ablation Devices
    • Radiofrequency Ablation Devices
    • Cryoablation Devices
  • Analgesic Infusion Pumps
    • Intrathecal Infusion Pumps
    • External Infusion Pumps

By Application

      • Neuropathic Pain
      • Cancer Pain
      • Musculoskeletal Pain
      • Facial Pain and Migraine
      • Others

By Country

  • Middle East and Africa
  • UAE
  • Saudi Arabia
  • South Africa

Company Profiles

  • Pfizer Inc
  • Abbott
  • Boston Scientific Corporation
  • Medtronic
  • BD
 
  1. Pfizer Inc
  2. Abbott
  3. Boston Scientific Corporation
  4. Medtronic
  5. BD
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the MEA pain management devices market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the North America pain management devices market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.